Heart toxicity from breast cancer radiotherapy Marc D. PirothRené BaumannRolf Sauer Review Article Open access 11 October 2018 Pages: 1 - 12
Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold Montserrat PazosAlba FiorentinoStefanie Corradini Original Article 24 August 2018 Pages: 13 - 20
Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome I. KindtsA. LaenenC. Weltens Original Article 23 August 2018 Pages: 21 - 31
Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy C. SimonettoH. RennauG. Hildebrandt Original Article 22 October 2018 Pages: 32 - 42
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy Giulio FrancoliniIsacco DesideriLorenzo Livi Original Article 07 November 2018 Pages: 43 - 51
Long-term endothelial dysfunction in irradiated vessels: an immunohistochemical analysis Raimund H. M. PreidlPatrick MöbiusFalk Wehrhan Original Article 15 October 2018 Pages: 52 - 61
Feasibility of radiotherapy in nonagenarian patients: a retrospective study L. KocikH. GeinitzC. Nieder Original Article 30 August 2018 Pages: 62 - 68
Is low dose radiotherapy an effective treatment for Baker’s cyst? Matthias G. HautmannErnst-Michael JungFranz Josef Putz Original Article 30 October 2018 Pages: 69 - 76
Heart-sparing volumetric modulated arc therapy for whole lung irradiation Alexandros PapachristofilouAnna-Lena HottingerUlrich Schratzenstaller Short Communication 06 September 2018 Pages: 77 - 82
Kombinierte Immuntherapie für Patienten mit Hirnmetastasen eines malignen Melanoms: Deeskalation nur unter kontrollierten Bedingungen und engmaschiger Bildgebung Carsten Nieder Literatur kommentiert 29 October 2018 Pages: 83 - 85
Adjuvante Radiotherapie bei der multimodalen Behandlung resektabler Magenkarzinome – Kritik an den Schlussfolgerungen aus CRITICS? Robert Michael HermannHans Christiansen Literatur kommentiert 29 October 2018 Pages: 86 - 89
Additive Chemotherapie mit Cisplatin und Gemcitabin nach kurativ intendierter Radiochemotherapie verbessert das rezidivfreie Überleben von Nasopharynxkarzinompatienten mit noch nachzuweisender EBV-DNA-Last nicht Christoph WillichThomas B. Brunner Literatur kommentiert 08 November 2018 Pages: 90 - 91